Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT05552976 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 525 participants |
| Active Locations | 36 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | February 11, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT05552976 is currently active_not_recruiting participants. This clinical trial study for multiple myeloma is not currently accepting new participants at 36 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05552976 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05552976 was last updated 2 weeks ago (February 11, 2026). HelloStudys verifies this status automatically.